{"university":{"openalex_id":"I200284239","name":"Universidade de Santiago de Compostela"},"topic":"age-crosslink-breakers","total_matching":2,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.1093/eurjhf/hfq117","title":"Soluble Receptor of Advanced Glycation End Products Levels are Related to Ischaemic Aetiology and Extent of Coronary Disease in Chronic Heart Failure Patients, Independent of Advanced Glycation End Products Levels","source_url":"https://doi.org/10.1093/eurjhf/hfq117","source_name":"European Journal of Heart Failure","cited_by_count":62,"is_open_access":true,"openalex_work_id":"W1493360866","publication_date":"2010-08-04","publication_year":2010,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]},{"doi":"https://doi.org/10.1186/1475-2840-11-102","title":"Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report","source_url":"https://doi.org/10.1186/1475-2840-11-102","source_name":"Cardiovascular Diabetology","cited_by_count":26,"is_open_access":true,"openalex_work_id":"W2024826493","publication_date":"2012-08-21","publication_year":2012,"university_research_work_topics":[{"topic_slug":"age-crosslink-breakers"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}